Literature DB >> 27769799

Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China.

A-Mei Zhang1, Cheng-Lin Zhang2, Yuzhu Song3, Ping Zhao4, Yue Feng3, Binghui Wang3, Zheng Li5, Li Liu3, Xueshan Xia6.   

Abstract

OBJECTIVES: About 2% of the world population is infected with hepatitis C virus (HCV), a leading cause of hepatic cirrhosis and hepatocellular carcinoma. The Niemann-Pick C1-like 1 cholesterol absorption receptor (NPC1L1) was recently identified to be an important factor for HCV entry into host cells. Whether genetic variations of the NPC1L1 gene are associated with HCV infection is unknown.
METHODS: In this study, five single nucleotide polymorphisms (SNPs) of the NPC1L1 gene were analyzed in 261 HCV-infected individuals and 265 general controls from Yunnan Province, China.
RESULTS: No significant differences were identified in genotypes or alleles of the SNPs between the two groups. After constructing haplotypes based on the five SNPs, a significant difference between HCV-infected individuals and general controls was shown for two haplotypes. Haplotype GCCTT appeared to be a protective factor and haplotype GCCCT was a risk factor for HCV-infected individuals. Genotypes of four SNPs correlated with biochemical characteristics of HCV-infected persons. Genotypes of SNPs rs799444 and rs2070607 were correlated with total bilirubin. Genotype TT of rs917098 was a risk factor for the gamma-glutamyltransferase level. Furthermore, HCV-infected individuals carrying genotype GG of rs41279633 showed statistically higher gamma-glutamyltransferase levels than HCV-infected persons with GT and TT.
CONCLUSION: The results of this study identified the association between genetic susceptibility of the NPC1L1 gene and HCV infection, as well as biochemical characteristics of HCV-infected persons in Yunnan, China.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Biochemical characteristics; HCV infection; NPC1L1 gene; SNPs

Mesh:

Substances:

Year:  2016        PMID: 27769799     DOI: 10.1016/j.ijid.2016.10.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Molecular cloning and characterization of NPC1L1 in the Chinese tree shrew (Tupaia belangeri chinensis).

Authors:  Xiuying Kui; Dandan Qiu; Wenguang Wang; Na Li; Pinfen Tong; Xiaomei Sun; Liangzi Jin; Wei Deng; Jiejie Dai; Caixia Lu
Journal:  Mol Biol Rep       Date:  2021-10-30       Impact factor: 2.316

Review 2.  Regulated Entry of Hepatitis C Virus into Hepatocytes.

Authors:  Zhijiang Miao; Zhenrong Xie; Jing Miao; Jieyu Ran; Yue Feng; Xueshan Xia
Journal:  Viruses       Date:  2017-05-09       Impact factor: 5.048

3.  The Niemann-Pick C1-like 1 rs2073547 polymorphism is associated with type 2 diabetes mellitus in a Chinese population.

Authors:  Zhenxing Huang; Ruyin Tan; Liheng Meng; Haiyan Yang; Xinghuan Liang; Yingfen Qin; Zuojie Luo
Journal:  J Int Med Res       Date:  2019-07-16       Impact factor: 1.671

4.  STAT3 signaling pathway plays importantly genetic and functional roles in HCV infection.

Authors:  Yuzhu Song; Xianyao Yang; Yunsong Shen; Yiqian Wang; Xueshan Xia; A-Mei Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-06-20       Impact factor: 2.183

Review 5.  Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.

Authors:  Matteo Pirro; Vanessa Bianconi; Daniela Francisci; Elisabetta Schiaroli; Francesco Bagaglia; Amirhossein Sahebkar; Franco Baldelli
Journal:  J Cell Mol Med       Date:  2017-07-18       Impact factor: 5.310

6.  Interleukin-6 polymorphisms in HCC patients chronically infected with HCV.

Authors:  Faisal Adnan; Najeeb Ullah Khan; Aqib Iqbal; Ijaz Ali; Arnolfo Petruzziello; Rocco Sabatino; Annunziata Guzzo; Giovanna Loquercio; Gerardo Botti; Sanaullah Khan; Muhammad Naeem; Muhammad Ismail Khan
Journal:  Infect Agent Cancer       Date:  2020-04-01       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.